SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-142093
Filing Date
2022-05-05
Accepted
2022-05-05 14:26:37
Documents
12
Period of Report
2022-05-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d342404d8k.htm   iXBRL 8-K 23360
  Complete submission text file 0001193125-22-142093.txt   145409

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arwr-20220502.xsd EX-101.SCH 2887
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20220502_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20220502_pre.xml EX-101.PRE 11282
6 EXTRACTED XBRL INSTANCE DOCUMENT d342404d8k_htm.xml XML 3361
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 22895530
SIC: 2834 Pharmaceutical Preparations